The company held 2016 annual board of directors, board of supervisors
Release time:
2020-08-14
Company Held 2016 Board of Directors and Board of Supervisors
to Review and Pass the Board's Work Report and Other Proposals and Reports
News 4# November 15 , the 11 Meeting of the 9th Board of Directors of the Group Company was held in Jianfeng Building, deliberated and passed 2016 Board of Directors Work Report, 2016 General Manager Work Report and other 14 proposals and reports. The
meeting was presided over by Jiang Xiaomeng, chairman of the group company. Yu Jianhong, general manager, made an annual work report on behalf of the management team, comprehensively summarizing and reviewing the company's 2016 work.
In 2016 , the company focused on the general policy of "innovation, integration, improvement, and development", actively sought new opportunities for development, made new breakthroughs in cooperative innovation, carried out in-depth management integration, continuously improved management levels, and strengthened marketing Management and market expansion have achieved steady growth in product sales, technological innovation and technological transformation have achieved obvious results, and corporate image and influence have been effectively improved. The company realized operating income of 23.79 .2 billion yuan for the whole year, up 5.34% year on year. Net profit attributable to owners of the parent company 28522.95 yuan, up 41.98% year on year, the highest level in history. By the end of 2016 , the company's total assets were 39.95 .2 billion yuan, up 10% year on year. Net assets were 25.52 .6 billion yuan, up 9.82 year on year.
2016 , thanks to the national strategy of "the belt and road initiative", the national cement production increased by 2.3% year-on-year, driven by the recovery of infrastructure investment and real estate investment. The growth of total demand, the development and construction of the southwest region and the implementation of a series of structural reform measures on the supply side of the cement industry, including peak production, industry self-discipline and market integration, cement prices rebounded after bottoming out in the first half of 2016 , and the cement industry in some areas improved. The company's cement business sector seized the opportunity of supply-side reform, actively advocated industry self-discipline, and worked closely around the cost-leading strategy. Daye Peak actively participated in large-scale project bidding while increasing the expansion of the civil market for bagged cement, striving to maintain the gross profit level of tons of cement and ensuring the balance of production and sales in the off-season market. Yunnan Peak strives to enhance the brand status of Peak Cement and advocates self-discipline in the cement industry in southwest Yunnan, actively develop key projects, continue to expand market share, and significantly improve economic efficiency.
Peak Pharmaceutical strives to seek new projects and make new breakthroughs according to strategic planning. In terms of business development, Jianfeng Pharmaceutical has introduced advanced German technology and established a Sino-German joint venture Zhejiang Jindal Baby Drug Co., Ltd. to build a platform specializing in the research and development, production and operation of infant drugs. After more than half a year of research and negotiation, it successfully reached an agreement with Beihui Biology's major shareholders to take a stake in Beihui Biology by way of capital increase and equity transfer. In terms of equity investment, the company also completed the capital increase of Peak Pharmaceuticals and Tianshili Group. In terms of product sales, efforts have been made to realize the entry of peak pharmaceutical products into various catalogues. Jinhua Pharmaceutical Company has obtained the qualification of main distribution in Yiwu primary hospitals. Peak pharmacy has added 4 chain stores and 4 designated medical insurance pharmacies, realizing sales growth. In terms of technological innovation, the research and development project of Jianfeng Pharmaceutical's new anti-tumor drug DPT (deoxypodophyllotoxin) is progressing smoothly, and it has obtained clinical trial approval documents issued by CFDA and obtained a number of related invention patents.
peak health food extraction workshop passed GMP certification, extraction workshop passed Kosher (clean food), halal (halal) certification, and passed ISO9001 , ISO22000 system on-site audit; Complete the drug production record of Ginkgo biloba extract and the establishment of GMP management system, complete the certification of SC for 5 unit foods such as jelly, flavored tea, plant beverages, etc. Tianjin Jianfeng Natural Products Company has strengthened the development of the domestic market while continuing to expand the international market, realizing the simultaneous growth of international and domestic market sales. Peak cable through the product system, Ter and other certification supervision and inspection, large logarithmic cable successfully entered the Hangzhou G20 project. At the same time, the company takes budget management and benchmarking management as the guidance, fine management and PDCA
also deliberated and approved the "plan on profit distribution for 2016
2016 , based on 2016 year-end share capital ,344,083, 828 shares, and distribute cash dividend 2.5 yuan (including tax) for every 10 shares, the total amount of cash dividends distributed to all shareholders registered on the date of record is 86,020,957.00 yuan (including tax), and 2016 will not be converted into share capital. The distribution plan still needs to be approved by the general meeting of shareholders. If it is implemented, the cash dividend accumulated by the company to shareholders in the last three years will reach 23397.70 .14 million yuan. On the same day, 115 , the company also held the 119 meeting of the 10th 118 of the 8th board of supervisors, deliberated and passed the 123 proposals and reports of the 5th board of supervisors of the company 2016 and the proposal on adding supervisors. (Zhou Hengbin)
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page